Awards

Le Fonti Awards 2018

Proving the Excellence of Sintetica.

Sintetica is recognised at this years Le Fonti Awards. Many world-class forces of the economy gathered over an evening event and witnessed Augusto Mitidieri being awarded for the second consecutive year the prestigious award of CEO of the Year for Corporate Social Responsibility.
For being an international force of excellence in the pharmaceutical sector, with particular reference to the treatment of pain. Thanks to its CEO's charisma and highly professional team, Sintetica has proven itself to be one of the fastest growing realities in the market and perfectly satisfies the CSR criteria.
[Le Fonti Awards]

The motivation of this acknowledgement comes from the material representation of the spirit, envisioned by Augusto Mitidieri and embodied by the entire company, with which Sintetica manages its impressive expansion on the global market, strengthened by products of the highest quality and efficiency.

The award of CEO of the Year for Corporate Social Responsibility is further acknowledgement of the excellent work Sintetica does as a whole.

<- Close

Business WorldWide 2018

Sintetica SA Named Europe's Pharmaceutical Company of the Year by Business Worldwide Magazine.

Swiss based pharmaceutical company Sintetica SA has another award to add to its already impressive collection, having been named 'Pharmaceutical Company of the Year - Europe' in the 2018 Brand of the Year Awards by Business Worldwide Magazine.
The 2018 Brand of the Year Awards recognize and reward organizations that have performed exceptionally over the previous 12 months, becoming dynamic forces within their industries. The judging panel look not only for businesses of world class quality, but those that strive to push boundaries, challenge perceptions and respond to global problems; earning respect from their peers and becoming employers of choice. Sintetica SA impressed the panel with its clear commitment to ongoing development, innovation and "quality without compromise" - the company's mantra.

Sintetica SA's CEO Augusto Mitidieri is leading the way in a new business model that encourages collaborative and horizontal working, combining state of the art technology with a human-centred approach. The company has come a long way since it was formed almost 100 years ago, going from a small business in Switzerland to a global company employing 300 people across 29 countries. Delivering injectable anaesthetics and analgesics to patients worldwide, the company has been the market leader in its field for many years and is now forging the way in the growing field of neuromodulation. The global division was only established in 2012, but growth is already exceeding 200% - a testament to the hard work and commitment of the CEO and his team.

Mitidieri says that the company's culture of respect has played an important role in its success. "What differentiates us from competitors is that all strategic choices are based on values of respect, a core value that permeates across every employee. It is about creating a pleasant environment in which employees can work and express themselves. When hiring new employees, we look for 'smart' people who share our thirst for diversity, our respect for traditions and our aim to be a leading global company."

This "people first" approach extends way beyond the staff team, positively affecting relationships with business partners and realizing the best possible care solutions for patients. Mitidieri's innovative new organization model, the 'Human Centered Organization', is based on the idea of responsibility and meritocracy rather than hierarchy, with managers moving from a role of command to a coaching style.

This refreshing approach certainly appears to be working. The company has recently obtained the go-ahead to market a new drug application in the United States; an outstanding achievement as one of the few small-medium sized companies in the world to register a new product in the US. It is also developing a radical new innovation in the field of post-surgery pain relief that has the potential to change the way pain is managed throughout the world.
<- Close

ACQ5 Awards 2018

ACQ Gamechangers™ Healthcare Awards 2018.

Pasquale Mitidieri, Global markets Corporate Director, tells us more about Global Division's growth.

CPhI Pharma Awards - 2018

Finalist - CPhI 2018 Madrid, Spain.

Le Fonti Awards 2017

The prestigious Le Fonti Awards reward Sintetica’s CEO.

This is decidedly a golden period for Sintetica SA, the pharmaceutical company from Canton Ticino specialized in products for pain therapy (www.sintetica.com). The CEO Augusto Mitidieri received a prestigious award in the internationalization category for the year 2017 from the Fonti Awards (www.lefontiawards.it).
The statement regarding Mitidieri's award is

"For his capacity to lead with foresight and attention to human resources in the context of an international specialization in injectable products for pain relief and therapy. In particular, for having invested in the education vand continuous training of the employees in terms of the global standards for Corporate social responsibility and foreign development."


the sentence was translated from Italian by Sintetica

The "Le Fonti" Awards are incorporated in the IAIR system of international awards, an event of great prominence for the business community. It reunites corporate leaders, legal offices and individuals from the highest tiers of the financial world.

This new award refines the already impressive recent prizes bestowed upon Sintetica SA as Pharmaceutical Company of the year 2016 Switzerland and upon Augusto Mitidieri as European CEO of the year 2016.

<- Close

Business Worldwide’s CEO Awards 2017

Augusto Mitidieri of Sintetica is European Pharmaceutical CEO Champion.

CEO of Sintetica SA Augusto Mitidieri is a worthy recipient of the Business Worldwide Magazine award Best CEO/Pharmaceutical Industry Europe 2017.

Ultimately in charge of 230 employees spread across 25 different countries, his job is incredibly strategic, thanks to competition from emerging countries and long-term austerity measures Europe-wide. But it's not all doom and gloom for this talented CEO. That's because today there is more investment in pharmaceutical research and development than ever before.

And Mitidieri is determined that Sintetica - whom he has worked with for the past 17years – will remain a leading player within the industry. The 95-year-old company develops injectable anaesthetics and analgesics on a global scale. These are specifically used for local anaesthesia, pain management and neuromodulation. Mitidieri regards development, production and marketing as crucial areas for the company's future strategy.

Receiving his Best CEO Award from the magazine's executives, Mitidieri insisted that innovation within his industry wasn't merely about products, but also management style and organisation.

"Getting this right has been one of the key elements of our success here at Sintetica"

he declared.

Sintetica has its HQ in Switzerland, where it employs around 40 per cent of the company's total workforce. Other countries in which it has a base includes Germany, Austria, Italy and the United Kingdom.
In order for sintetica to retain its global leadership peg Mitidieri believes strategic partnering and business development are the keys to long-term growth.
"Our specialist sales teams in Switzerland, Germany, Austria, the UK and Ireland directly promote and market our products, while our Global Division delivers our top medicines through a network of strategic international worldwide partners" ex-lained Mitidieri, who is a graduate in Management Engineering from the Politecnico di Milano.
He is hardly apologetic in admitting his 'pickiness' when it comes to choosing business partners. They must share the values of Sintetica, particularly its way of prioritising people and relationships over profit.

"All our partners must meet strict ethical criteria and share our innovation-driven quality without compromising our value proposition"

said Mitidieri.
As you would expect, Sintetica is a company which regards staff as a core resource. As such Mitidieri strives to offer a creative culture and doesn't even mind risk taking too much, provided it's what he would describe as "informed".
He added:

"Making Sintetica a great place to work is our belief and is, in fact, part of our DNA."

<- Close

European Enterprise Awards - 2017

Sintetica SA - Best Pharmaceutical Company 2017 - Switzerland.

CPhI Pharma Awards - 2017

Finalist - CPhI 2017 Messe Frankfurt,
Germany.

ACQ5 Awards - 2017

ACQ5 Awards - Growth Company of the year 2017.

Can respect be the key to global growth in the pharmaceutical industry?

Worldwide Business Review - 2017

Winner of the awards Excellence in
HR - Managing Director & Vp, Human
Resource of the year 2017.

CV Magazine Awards - 2017

Sintetica, man at the centre

The palmarès of Sintetica SA Mendrisio, the oldest pharmaceutical company in the Canton Ticino, has been recently enriched with new important international awards.

Such acknowledgments are actually marking the pace of the Corporate’s signicant growth, which is also active in the international markets.

CV magazine has awarded once again Sintetica for the year 2017, in the small business section, as the best European pharmaceutical company. At the same time, Mr. Augusto Mitidieri, Sintetica’s CEO, earned the title of the best pharmaceutical CEO in the world. The main reason behind the attribution of the two prizes lies in the total respect as core value of Sintetica, recognized as a distinctive strategic factor in the entire pharma panorama. Likewise, in order to assure absolute excellence, Mr. Mitidieri, CEO, is now committed to building a "human-centric" corporate culture.

CV Magazine - Small Business Awards 2016

Sintetica® Pharmaceutical Company of the year 2016 Switzerland.

European CEO of the year 2016

European CEO of the year 2016 Augusto Mitidieri - Sintetica.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.